PTPN11 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

26 results for “PTPN11”

Trials

View all 12 →

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

70 participants · First posted Feb 21, 2023

A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

210 participants · First posted Dec 23, 2025

Safety and Efficacy of Inhaled Synthetic THC/CBD for Improving Physical Functioning and for Modulating Cachexia Progression in Patients With Advanced Cancer and Associated Cachexia

334 participants · First posted Jun 27, 2019

Drugs

PTPN13/fas inhibitors (pulmonary fibrosis)

PTPN1/N2 checkpoint inhibitor (cancer)

PTPN2 inhibitors (CD3)

News

Tumour Genetic Variants Linked to Immunotherapy Toxicity Risk in Urothelial Cancer

Kura Oncology and Kyowa Kirin's Ziftomenib Achieves Primary Endpoints in Phase II AML Trial

Mondego Bio Advances AI-Designed PTPN2 Inhibitor ZE00-0388 to Phase 1 Clinical Trials

Page 1 of 3